Hi Gina,
actually I haven't heard of this one specifically but am aware of the research in this field. It's early days yet to say if it might be helpful for arach. and altho' AA mimics MS in some symptoms, there is a different pathology and really the path we need to go down is:
(a) reduce scar tissue
(b) prevent further inflammation
(c) prevent scar recurrence
(d) treat residual deficit
Step (b) and (c) are the major problem areas. This new drug might tackle step (b) but that
and hence perhaps (c) but the risks are high if it fails as step (a) would entail sugery which has the potential to really exacerbate the problem severely.
I keep my ears and eyes open all the time for new possibilities and will obviously share any hopeful findings as soon I as I get them!!
Regards,
DocSarah